Phase 1/2CompletedAge-related condition
Mesenchymal Stem Cells in Critical Limb Ischemia
A Randomized, Double Blind, Multicentric, Placebo Controlled, Single Dose, Phase - i/ii Study Assessing the Safety and Efficacy of Intramuscular ex Vivo Cultured Adult Allogenic Mesenchymal Stem Cells in Patients With Critical Limb Ischemia (Cli)
- Sponsor
- Stempeutics Research Pvt Ltd (Industry)
- Enrollment
- 20 enrolled
- Conditions
- Critical Limb Ischemia
- Interventions
- mesenchymal stem cells; Plasmalyte A
- Ages
- adults
- Registry
- NCT00883870
Full record on ClinicalTrials.gov
From the registry
This clinical trial aims to study the safety and efficacy of adult mesenchymal stem cells in critical limb ischemia.
Primary outcomes
- AE and symptomatic relief
History
Last registry update
Study completion
Primary completion
Registered
Started